{
    "laboratory_examinations": [
        {
            "procedure_name": "Complete Blood Count",
            "date": "Not specified",
            "findings": "Results were normal.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Alkaline Phosphatase",
            "date": "Not specified",
            "findings": "Blood level was 119 U per liter (reference range, 30 to 100); outside normal range.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "MRI Scan",
            "date": "12 years after initial resection",
            "findings": "Showed residual T2-weighted hyperintensity along the margin of the resection cavity.",
            "changes_over_time": "Gradual development of abnormal, nonenhancing, mildly expansile tissue with T2-weighted hyperintensity was noted."
        },
        {
            "procedure_name": "Genetic Testing",
            "date": "At current presentation",
            "findings": "Revealed IDH1 R132H mutation and presence of MGMT gene promoter methylation.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "MRI Scan",
            "date": "Immediately after second resection",
            "findings": "Showed stable appearance and extent of signal abnormality in infiltrative neoplasm.",
            "changes_over_time": "Follow-up MRIs after chemotherapy showed a decrease in the degree of infiltration and extent of abnormal tissue."
        },
        {
            "procedure_name": "Ki-67 Proliferation Index",
            "date": "At second resection",
            "findings": "Ki-67 proliferation index was 9%, higher than typically associated with WHO grade II oligodendrogliomas.",
            "changes_over_time": "Not specified."
        }
    ]
}